Portable Handheld Device for Glaucoma Screening and Diagnosis
Glaucoma stands as the leading cause of irreversible blindness worldwide after cataract. It is expected to affect 111.8 million people by 2040 [1], exacerbates by the aging population globally. Despite its prevalence, 50% of people with glaucoma are undiagnosed. Current methods of imaging the iridocorneal angle for glaucoma diagnosis are severely limited by cost and utility, with traditional gonioscopy being the main method. Gonioscopy is a subjective procedure and the method causes discomfort in patients.
This technology is a compact, handheld device specifically designed to enhance the accessibility of glaucoma diagnosis. With its portable and user-friendly design, it enables the evaluation and automated diagnosis of glaucoma angle, making it suitable for use by non-specialists. The device is complemented by advanced image processing and management software, which facilitates precise and automated angle evaluation, ensuring accurate and efficient diagnostics.
The technology owner seeks collaboration with partners interested in development and licensing opportunities. Medical device manufacturers, technology firms, or individuals passionate about advancing innovative healthcare solutions are invited to collaborate or license the technology. Partnerships can focus on optimizing the design, scaling production, and facilitating successful market entry.
[1] Tham, Y., Li, X., Wong, T. Y., Quigley, H. A., Aung, T., & Cheng, C. (2014). Global Prevalence of Glaucoma and Projections of Glaucoma Burden through 2040. Ophthalmology, 121(11), 2081–2090. https://doi.org/10.1016/j.ophtha.2014.05.013